Peter Huppke

2.1k total citations
39 papers, 1.1k citations indexed

About

Peter Huppke is a scholar working on Pathology and Forensic Medicine, Neurology and Molecular Biology. According to data from OpenAlex, Peter Huppke has authored 39 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pathology and Forensic Medicine, 12 papers in Neurology and 6 papers in Molecular Biology. Recurrent topics in Peter Huppke's work include Multiple Sclerosis Research Studies (23 papers), Peripheral Neuropathies and Disorders (9 papers) and Polyomavirus and related diseases (5 papers). Peter Huppke is often cited by papers focused on Multiple Sclerosis Research Studies (23 papers), Peripheral Neuropathies and Disorders (9 papers) and Polyomavirus and related diseases (5 papers). Peter Huppke collaborates with scholars based in Germany, United States and Switzerland. Peter Huppke's co-authors include Jutta Gärtner, Brenda Huppke, Wiebke Stark, Wolfgang Brück, Kevin Rostásy, David Ellenberger, Markus Reindl, Michael Karenfort, Hendrik Rosewich and Astrid Blaschek and has published in prestigious journals such as Neurology, Annals of Neurology and The American Journal of Human Genetics.

In The Last Decade

Peter Huppke

36 papers receiving 1.1k citations

Peers

Peter Huppke

PFM

NEURO

RHEUM

HEMAT

Irena Dujmović Serbia

Channa Kolb United States

James Stankiewicz United States

M. A. Kelly United Kingdom

Elisa Tsao United States

Beata Zakrzewska‐Pniewska Poland

Klaus Tiel‐Wilck Germany

Ann Dring United Kingdom

Elisabetta Zardini Italy

R. Egg Austria

Irena Dujmović Serbia

Peter Huppke

1.0k ×1.4

PFM

656 ×1.3

NEURO

389 ×1.8

RHEUM

279 ×1.6

67 ×0.4

HEMAT

Citations per year, relative to Peter Huppke Peter Huppke (= 1×) peers Irena Dujmović

Countries citing papers authored by Peter Huppke

Since Specialization

Citations

This map shows the geographic impact of Peter Huppke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Huppke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Huppke more than expected).

Fields of papers citing papers by Peter Huppke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Huppke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Huppke. The network helps show where Peter Huppke may publish in the future.

Co-authorship network of co-authors of Peter Huppke

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Huppke. A scholar is included among the top collaborators of Peter Huppke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Huppke. Peter Huppke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kadas, Ella Maria, Hanna Zimmermann, Peter Huppke, et al.. (2025). The Inner Nuclear Layer in Pediatric Multiple Sclerosis. Neurology Neuroimmunology & Neuroinflammation. 12(3). e200387–e200387.

Krätzner, Ralph, Gajja S. Salomons, Peter Dechent, et al.. (2024). Long term follow-up in GAMT deficiency – Correlation of therapy regimen, biochemical and in vivo brain proton MR spectroscopy data. Molecular Genetics and Metabolism Reports. 38. 101053–101053. 2 indexed citations

Bertrand, Miriam, Brent S. Pedersen, Alexander Schulz, et al.. (2024). De novo AHDC1 Deletions Identified by Genome Sequencing in Two Individuals with Xia-Gibbs Syndrome. Molecular Syndromology. 15(5). 389–397.

Krupp, Lauren, Brenda Banwell, Tanuja Chitnis, et al.. (2022). Effect of fingolimod on health-related quality of life in paediatric patients with multiple sclerosis: results from the phase 3 PARADIGMS Study. BMJ Neurology Open. 4(1). e000215–e000215. 8 indexed citations

Dost, Axel, et al.. (2021). Autoimmune Encephalitis in an Infant with Biallelic AIRE Variants: Unusual Manifestation of Autoimmune Polyendocrinopathy Syndrome Type 1 (APS-1)?. Neuropediatrics.

Chitnis, Tanuja, Brenda Banwell, Lauren Krupp, et al.. (2020). Temporal profile of lymphocyte counts and relationship with infections with fingolimod therapy in paediatric patients with multiple sclerosis: Results from the PARADIGMS study. Multiple Sclerosis Journal. 27(6). 922–932. 7 indexed citations

Benkert, Pascal, Jens Wuerfel, Zuzanna Michalak, et al.. (2020). Serum neurofilament light chain is a useful biomarker in pediatric multiple sclerosis. Neurology Neuroimmunology & Neuroinflammation. 7(4). 44 indexed citations

Chandratre, Saleel, Olga Ciccarelli, J. de Sèze, et al.. (2020). Treatment of MOG antibody associated disorders: results of an international survey. Journal of Neurology. 267(12). 3565–3577. 9 indexed citations

Huppke, Brenda, et al.. (2019). Association of Obesity With Multiple Sclerosis Risk and Response to First-line Disease Modifying Drugs in Children. JAMA Neurology. 76(10). 1157–1157. 61 indexed citations

10.

Deiva, Kumaran, Peter Huppke, Brenda Banwell, et al.. (2019). Consistent control of disease activity with fingolimod versus IFN β-1a in paediatric-onset multiple sclerosis: further insights from PARADIGMS. Journal of Neurology Neurosurgery & Psychiatry. 91(1). jnnp–2019. 20 indexed citations

11.

Kitze, Bernd, et al.. (2015). Apheresis in treatment of acute inflammatory demyelinating disorders. Atherosclerosis Supplements. 18. 251–256. 23 indexed citations

12.

Weygandt, Martin, Katharina Schregel, Kerstin Ritter, et al.. (2014). MRI-based diagnostic biomarkers for early onset pediatric multiple sclerosis. NeuroImage Clinical. 7. 400–408. 7 indexed citations

13.

Koziolek, Michael, Tim Friede, David Ellenberger, et al.. (2013). Therapeutic Apheresis in Pediatric Patients with Acute CNS Inflammatory Demyelinating Disease. Blood Purification. 36(2). 92–97. 24 indexed citations

14.

Huppke, Peter, Cornelia Brendel, Vera M. Kalscheuer, et al.. (2012). Mutations in SLC33A1 Cause a Lethal Autosomal-Recessive Disorder with Congenital Cataracts, Hearing Loss, and Low Serum Copper and Ceruloplasmin. The American Journal of Human Genetics. 90(2). 378–378. 3 indexed citations

15.

Huppke, Peter & J Gärtner. (2010). A Practical Guide to Pediatric Multiple Sclerosis. Neuropediatrics. 41(4). 157–162. 14 indexed citations

16.

Huppke, Peter, et al.. (2008). Natalizumab Use in Pediatric Multiple Sclerosis. Archives of Neurology. 65(12). 1655–8. 70 indexed citations

17.

Brockmann, Knut, et al.. (2005). Visually Self‐induced Seizures Sensitive to Round Objects. Epilepsia. 46(5). 786–789. 1 indexed citations

18.

Huppke, Peter, Kai Kallenberg, & Jutta Gärtner. (2005). Perisylvian polymicrogyria in Landau–Kleffner syndrome. Neurology. 64(9). 1660–1660. 13 indexed citations

19.

Lakomek, M., H. Winkler, Arnulf Pekrun, et al.. (1994). Erythrocyte Pyruvate Kinase Deficiency. 48(3). 149–163. 13 indexed citations

20.

Lakomek, M., Peter Huppke, Bernd A. Neubauer, et al.. (1994). Mutations in the R-type pyruvate kinase gene and altered enzyme kinetic properties in patients with hemolytic anemia due to pyruvate kinase deficiency. Annals of Hematology. 69(5). 253–260. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact